Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2 von Nguyen, Linh T., Saibil, Samuel D., Sotov, Valentin, Le, Michael X., Khoja, Leila, Ghazarian, Danny, Bonilla, Luisa, Majeed, Habeeb, Hogg, David, Joshua, Anthony M., Crump, Michael, Franke, Norman, Spreafico, Anna, Hansen, Aaron, Al-Habeeb, Ayman, Leong, Wey, Easson, Alexandra, Reedijk, Michael, Goldstein, David P., McCready, David, Yasufuku, Kazuhiro, Waddell, Thomas, Cypel, Marcelo, Pierre, Andrew, Zhang, Bianzheng, Boross-Harmer, Sarah, Cipollone, Jane, Nelles, Megan, Scheid, Elizabeth, Fyrsta, Michael, Lo, Charlotte S., Nie, Jessica, Yam, Jennifer Y., Yen, Pei Hua, Gray, Diana, Motta, Vinicius, Elford, Alisha R., DeLuca, Stephanie, Wang, Lisa, Effendi, Stephanie, Ellenchery, Ragitha, Hirano, Naoto, Ohashi, Pamela S., Butler, Marcus O.

Volltext